Zum Inhalt

Transcultural adaptation and validation of the QUALEFFO-41 Questionnaire for Hebrew-Speaking Israeli women with postmenopausal osteoporosis with and without vertebral fractures

  • Open Access
  • 28.05.2025
  • Original Article
Erschienen in:

Abstract

Summary

To address cultural relevance in assessing osteoporosis-related quality of life, we validated and assessed the psychometric properties of the Hebrew version of QUALEFFO-41. The tool showed moderate reliability and validity, with diagnostic performance comparable to EQ-5D. This supports its clinical utility in Hebrew-speaking women with postmenopausal osteoporosis and vertebral fractures.

Background

Osteoporosis and its associated vertebral fractures significantly impact the quality of life among postmenopausal women. The Quality-of-Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO-41) is widely used to assess the quality of life in patients with osteoporotic spinal fractures but requires proper cultural adaptation for different populations.

Purpose

To translate, culturally adapt, and validate the QUALEFFO-41 questionnaire for Hebrew-speaking Israeli women with osteoporotic vertebral fractures (OVFs) and to compare its validity with the previously validated EQ-5D questionnaire in Israel.

Methods

The study included 155 postmenopausal women aged 50–90 years: 49 with osteoporotic vertebral fractures (OVF group) and 106 with osteoporosis but no fractures (OPC group). The QUALEFFO-41 was translated following international guidelines and tested for reliability, validity, and sensitivity. Statistical analysis included internal consistency (Cronbach’s alpha), test-retest reliability, discriminant and convergent validity, and ROC curve analysis.

Results

The Hebrew QUALEFFO-41 demonstrated good internal consistency (Cronbach’s alpha = 0.88) and test-retest reliability. Most questions (90% in the OVF group and 97% in the OPC group) showed good to excellent correlations. Both QUALEFFO-41 and EQ-5D questionnaires showed sufficient sensitivity in diagnosing women with osteoporosis and fractures (AUC = 0.767 and 0.756, respectively).

Conclusion

The Hebrew version of QUALEFFO-41 demonstrates moderate reliability and validity properties for assessing quality of life in Israeli postmenopausal women with osteoporosis and vertebral fractures. The questionnaire shows satisfactory psychometric properties, though certain domains may benefit from further refinement.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Introduction

Osteoporosis, a systemic skeletal disease marked by low bone mass and microarchitectural bone tissue deterioration, poses a global public health challenge [1]. As the population ages, osteoporosis and its associated complications, notably osteoporotic vertebral fractures (OVFs), are expected to increase [2]. OVFs occur when the spinal vertebrae weaken to the point of compression or fracture, often resulting in chronic lower back pain [3]. This persistent pain, coupled with the physical limitations imposed by OVFs, can significantly diminish a patient’s quality of life, leading to physical deformity and functional impairment [4, 5]. Despite their significant impact, OVFs frequently go undiagnosed and untreated due to their insidious nature [6]. This underdiagnosis and undertreatment exacerbate the burden of OVFs on individuals and healthcare systems, highlighting the urgent need for reliable and valid assessment tools [6].
Assessing the quality of life is an integral part of managing osteoporosis. Beyond objective clinical indicators, it is essential to consider subjective factors like the patient’s perception of their functioning and health. Over the years, various questionnaires have been developed to assess the quality of life in women with osteoporosis and back pain. The most commonly used questionnaire in clinical studies is the Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO-41), created by the European Association for Osteoporosis, specifically for patients with osteoporotic spinal fractures [7]. This questionnaire distinguishes between women with osteoporosis and fractures and those without fractures, covering various areas like pain, physical and social functions, the patient’s perception of their general health state, and mental function. Since its creation, the questionnaire has been translated and validated in many languages [814]. Despite the recognized importance of quality-of-life evaluation, many such available instruments are not routinely implemented in clinical settings.
The transcultural adaptation and translation of scientific questionnaires are critical to global research [1517]. As scientific inquiry becomes more globalized, data collection tools must be universally understandable and culturally appropriate. Properly validated and reliable tests are fundamental for accurate clinical decisions, diagnoses, and prognoses [1517]. Using invalidated or unreliable instruments can significantly affect a study’s results, leading to skewed findings and potential misinterpretations [16]. Therefore, ensuring these tools’ cultural and linguistic appropriateness helps maintain research integrity, enabling accurate, comparable data across diverse populations. This, in turn, fosters informed decision-making and contributes to advancing global health outcomes. Crucially, the QUALEFFO-41 questionnaire must be culturally adapted to the population it is being administered to.
This study aimed to translate and culturally adapt the QUALEFFO-41 into Hebrew for Israeli women diagnosed with osteoporotic spine fractures, evaluate its reliability among this population, and validate the Hebrew version. Furthermore, it aimed to compare the validity of the culturally adapted QUALEFFO-41 questionnaire with the EQ-5D questionnaire, previously validated in Israel, for the same target population [18].

Methods

Translation and cultural adaptation of the QUALEFFO-41 questionnaire

The translation process employed professional translators with relevant research backgrounds. A physiotherapist specializing in osteoporosis and a translator unassociated with the field, fluent in English and Hebrew, performed the initial translation. The questionnaire was then back-translated into English by another therapist experienced in osteoporosis and a translator fluent in Hebrew and English. After discussing and reaching a consensus, the translators determined the final Hebrew version of the questionnaire. This version was then pretested on a small group of 15 women from the target population to ensure appropriateness and comprehensibility.

Research tools

QUALEFFO-41 questionnaire [7]

A specific, self-administered questionnaire developed by the Working Party for Quality of Life of the European Foundation for Osteoporosis (EFFO). It comprises 41 items across five domains: pain (5 questions), physical functioning (17 questions), social functioning (7 questions), general health perception (3 questions), and mental functioning (9 questions). Most questions have five response options, except for questions 23–26 (three options) and 27–29 (four options). Scores are calculated by summing points and applying a linear transformation to a 0–100 scale. Higher scores indicate poorer quality of life.

EQ-5D questionnaire [19]

A general, self-administered questionnaire designed to assess health status. The first part includes five questions, each with three response options. Scoring follows the instructions provided in the “User’s Guide.” The second part, a visual analog scale (VAS), allows patients to rate their current quality of life on a scale from 0 to 100. This questionnaire was previously validated in Israel [18]. Participants received both questionnaires simultaneously and were instructed to complete them. The questionnaires were anonymized but coded for identification.

Sample size determination

Our objective was to obtain a sample size exceeding 100, which, according to Consensus-based Standards for the Selection of Health Measurement Instruments (COSMIN) standards, is deemed “very good” for evaluating construct validity, measurement error, reliability, and internal consistency. These standards rate a sample size of 50–99 as “adequate,” 30–49 as “doubtful,” and anything less than 30 as “inadequate” [17]. In the context of our study, a sample of 100 should include both osteoporotic patients with vertebral fractures and osteoporotic control subjects without fractures.

Clinical setting and recruitment procedures

The research was conducted within the Continuing Care and Home Hospitalization Unit at Clalit Health Services, Jerusalem District. Participants were recruited from seven primary care clinics in the Jerusalem District of Clalit Health Services (Ramot Eshkol, Mekor Baruch, Kiryat Yovel, Beit HaKerem, Maoz, German Colony, and Metudela) and the Ramot Eshkol Physiotherapy Institute.
Recruitment occurred through three channels: (1) direct referral by physiotherapists who identified eligible patients during treatment, (2) response to study advertisements posted in clinics and physiotherapy institutes, and (3) database screening of Clalit Health Services records following approval from the Data Extraction Committee. For the test–retest reliability assessment, 20 participants (10 from each group) were randomly selected to complete the QUALEFFO-41 questionnaire twice at a 2-week interval, either at their homes or at the clinic. The questionnaires were self-administered and completed outside of treatment sessions.

Inclusion and exclusion criteria

Inclusion criteria for the study were only Jewish (Ashkenazi or Sephardic), postmenopausal women aged 50–90 years diagnosed with osteoporosis. Those with at least one spinal fracture and no history of osteoporotic fractures in other areas were categorized into the OVF group, while those without spinal fractures comprised the OPC group. Exclusion criteria included women in an acute condition within a month following a spinal fracture, women with dementia, those unable to read Hebrew, as well as those diagnosed with secondary osteoporosis due to factors such as drug use, metabolic bone disease, end-stage renal failure, heart failure, or tumors. Additionally, women with other pathological conditions causing functional limitations or chronic back pain due to various diagnoses, such as disc herniations, spondylolysis, spondylolisthesis, and spondyloarthropathy, were excluded.

Statistical analysis

Data were analyzed using SPSS version 24. A p-value of 0.05 or less was considered a priori to indicate statistical significance for all research outcomes. Descriptive statistics (means, standard deviations, and percentages) were employed to analyze demographic characteristics. Chi-square and T-tests were used to compare categorical and continuous variables between the study and control groups. The same descriptive statistics were used to compare questionnaire scores within each group, including the floor and ceiling effects. The latter measures the proportion of subjects with the lowest and highest possible scores, respectively, with high values indicating difficulty in differentiating subjects or assessing changes after an intervention.
Reliability was tested via internal consistency, assessing item homogeneity within the test, and the test–retest method, assessing tool stability through repetition under identical conditions. Internal consistency was measured using Cronbach’s alpha, with a value of 0.70 or greater deemed satisfactory, while the ICC test was used to assess test–retest reliability.
For validity, discriminant and convergent validity tests were conducted using Pearson correlation for the QUALEFFO-41 questionnaire and Spearman correlation for the EQ-5D questionnaire. Concurrent validity was assessed using the EQ-5D questionnaire as the gold standard, examining the correlation between similar sections of both questionnaires. The degree of association was evaluated using a Spearman correlation.
The sensitivity of the questionnaires was measured via the area under the receiver operating characteristic (ROC) curve, which reflects the sensitivity and specificity of the questionnaire. We considered an area under the curve (AUC) of 0.7 or higher as marginally adequate in terms of sensitivity. The cutoff score for the questionnaire was calculated using the Youden index. We considered correlation coefficient (CC) values as follows: 0–0.20 indicates a poor correlation, 0.21–0.40 as medium, 0.41–0.60 as good, 0.61–0.80 as very good, and 0.81–1 as excellent. For comparing the discriminative abilities of the QUALEFFO-41 and EQ-5D questionnaires, we calculated the statistical significance of the difference between their respective areas under the curve (AUC). The comparison was performed using the formula Z = (AUC1 − AUC2)/√ (SE12 + SE22), where AUC1 and AUC2 represent the respective AUC values, and SE1 and SE2 represent their standard errors. The resulting Z-score was then converted to a p-value using the standard normal distribution, with p < 0.05 considered statistically significant. This method allows for direct comparison of the diagnostic accuracy between the two questionnaires while accounting for their respective standard errors.

Results

Translation

The questionnaire was translated into Hebrew and back-translated into English per the methodological protocol. Adjustments were made to accommodate the Israeli population, including alterations in measurement units and culturally relevant activities (e.g., going to synagogue). The International Osteoporosis Foundation approved the English version after two revisions. A pilot trial involving 15 women affirmed its comprehensibility and relevance, and no further changes were made.

Participants

The study involved 155 postmenopausal women aged 50–90, of which 49 were in the OVF group. The average age of this group was 76.84 ± 8.13 years. The OPC group, with an average age of 70.42 ± 8.08 years, comprised 106 women. Five participants withdrew due to specific back pain from a new disc herniation or failure to comply with the inclusion criteria due to osteopenia. The two groups had no significant differences regarding origin, marital status, or work type. Demographic details are presented in Table 1.
Table 1
Demographics
 
OVF group (n = 49)
Control (n = 106)
Significance
Age
70.42 ± 8.13
70.42 ± 8.08
p < 0.001
Years lived with menopause
20.63 ± 9.33
20.63 ± 9.33
p < 0.001
Type of occupation in the past
  Office work
45.2%
25.6%
p = 0.03
  Physical
54.8%
74.4%
  Years of education
12.67 ± 4.17
13.88 ± 3.33
p = 0.082
Marital status
  Widow
39.6%
24.8%
p = 0.178
  Divorced
12.5%
8.6%
  Single
6.2%
7.6%
  Married
41.7%
59%
Ethnicity
  Ashkenazi
41.5%
42%
p = 0.95
  Sephardic
58.5%
58%
Continuous data was tested with an independent student t-test. Data in percentages was tested with the χ2 test

Questionnaire results

The QUALEFFO-41 and EQ-5D questionnaires reflected a poorer quality of life among the study group compared to the control group. The QUALEFFO-41 questionnaire showed a ceiling effect in pain and basic daily activities for both groups, but no significant floor effect. Detailed scores and distributions can be found in Table 2.
Table 2
Comparison of the mean scores of the QUALEFFO-41 and EQ-5D questionnaires and data on “floor effect” and “ceiling effect”
Questionnaire/field
Mean (SD)
p-value
Floor (%)
Ceiling (%)
OVF
OPC
OVF
OPC
OVF
OPC
QUALEFFO-41
39.46 (16.8)
23.72 (13.9)
p < 0.001
2
0.9
2
0.9
Pain
41.35 (30.52)
27.45 (26.06)
0.004
6.1
0.9
22.4
34
Basic daily activities
23.6 (22.4)
10.31 (11.3)
p < 0.001
2
0.9
16.3
25.5
Household tasks
43.07 (24.16)
20.14 (21.05)
p < 0.001
2
0.9
8.2
20.8
Mobility
39.03 (23.2)
18.32 (18)
p < 0.001
2
0.9
2
9.4
Leisure and social activity
45.34 (28.26)
25.83 (21.20)
p < 0.001
6.1
0.9
6.1
14.2
General health condition
58.67 (24.8)
41.11 (22.95)
p < 0.001
8.2
2.8
2
2.8
Mental functioning
41.34 (14.71)
30.49 (14.07)
p < 0.001
2
0.9
2
0.9
EQ-5D
  HSV
0.5 (0.22)
0.26 (0.25)
p < 0.001
    
  VAS
73.9 (19.23)
81.44 (14.96)
0.11
    
OVF osteoporotic vertebral fracture group, OPC osteoporotic control group, HSV health state value

Reliability

The Cronbach’s alpha coefficient for the QUALEFFO-41 questionnaire was α = 0.88 for both groups, indicating good internal consistency, except in the OPC group’s mental, leisure, and social activity domains)α = 0.67(. The EQ-5D questionnaire showed lower consistency, with α = 0.77 in the OVF group and α = 0.70 in the OPC group. A repeat test showed good to excellent correlations in most areas for both groups (Table 3).
Table 3
Internal consistency reliability of QUALEFFO-41
Field
Cronbach α (range)
ICC* median (range)
OVF
OPC
OVF (n = 10)
OPC (n = 10)
QUALEFFO-41
0.88
0.88
Pain
0.91 (0.88–0.92)
0.89 (0.85–0.88)
0.47 (0.44–0.8)
0.64 (0.49–0.74)
Basic daily activities
0.80 (0.67–0.88)
0.70 (0.53–0.82)
0.77 (0.06–0.86)
––
Household tasks
0.85 (0.79–0.84)
0.87 (0.80–0.86)
0.87 (0.42–0.94)
0.57 (0.29–1)
Mobility
0.88 (0.86–0.89)
0.87 (0.85–0.89)
0.83 (0.59–0.94)
0.85 (0.19–1)
Leisure and social activity
0.83 (0.78–0.84)
0.67 (0.59–0.69)
0.72 (0.49–0.98)
0.61 (0.33–0.76)
General health condition
0.80 (0.54–0.84)
0.76 (0.54–0.85)
0.59 (0–0.63)
0.29 (0.17–0.99)
Mental functioning
0.64 (0.53–0.70)
0.69 (0.61–0.70)
0.78 (0.61–0.92)
0.9 (0.46–1)
EQ-5D
  HSV
0.77
0.70
HSV health state valve
*Spearman correlation coefficient

Validity

The construct validity of the QUALEFFO-41 questionnaire was assessed using discriminant and convergent validity, with correlations evaluated using Pearson’s correlation coefficient. In the study group, 37 out of 41 questions (90%) showed good to excellent correlations, with the remaining four questions belonging to the mental domain. The correlation index ranged from 0.89 to 0.79 for pain, 0.89 to 0.71 for basic daily activities, 0.83 to 0.73 for housework, 0.83 to 0.62 for mobility, 0.85 to 0.59 for leisure and social activities, 0.92 to 0.78 for general health, and 0.78 to 0.3 for mental functioning.
Regarding discriminant validity, most QUALEFFO-41 questions (89%) showed higher correlations with their domain than with other domains, except for one question in the mental domain. For convergent validity, most questions showed a satisfactory relationship with expected variables, namely basic daily activities, household tasks, mobility, leisure and social activities, general health condition, and mental functioning (67%), except for three questions in the mental domain. In the control group, 40 questions (97%) exhibited good to excellent correlations, with the remaining questions belonging to the leisure domain. The correlation index ranged from 0.88 to 0.74 for pain, 0.83 to 0.64 for basic daily activities, 0.92 to 0.75 for housework, 0.83 to 0.48 for mobility, 0.70 to 0.22 for leisure and social activities, 0.87 to 0.72 for general health, and 0.73 to 0.41 for mental functioning. Regarding discriminant validity, most questions showed higher correlations with their domain compared to other domains (57%), except for four questions in the leisure and social activity domain. For convergent validity, most questions demonstrated satisfactory correlations (86%), except for one in the leisure and social activity domain. These findings are presented in Table 4.
Table 4
Correlation between QUALEFFO-41 and EQ-5D domains
QUALEFFO-41
EQ-5D
Spearman correlation coefficient
p-value
Pain
Pain
0.67
p < 0.001
Basic daily activities
Self-care
0.51
p < 0.001
Household tasks and leisure activities
Daily life
0.65
p < 0.001
Mobility
Mobility
0.69
p < 0.001
Mental functioning
Anxiety/depression
0.54
p < 0.001

Sensitivity and specificity

The ROC curve analysis showed sufficient sensitivity of both QUALEFFO-41 and EQ-5D questionnaires in diagnosing women with osteoporosis and fractures. The area under the curve (AUC) was 0.767 (0.043) for QUALEFFO-41 and 0.756 (0.041) for EQ-5D. Comparative analysis of the discriminative abilities between these questionnaires revealed no statistically significant difference (difference = 0.011, Z = 0.185, p = 0.853), suggesting both questionnaires demonstrate comparable effectiveness in discriminating between women with and without vertebral fractures. The domains showed varying levels of predictive ability, with physical function demonstrating good discrimination (AUC = 0.75 [0.043] for QUALEFFO-41 and 0.77 [0.041] for EQ-5D), while the pain domains showed lower discrimination (AUC = 0.63 [0.050] for QUALEFFO-41 and 0.68 [0.05] for EQ-5D). Detailed scores for each domain are in Table 5, and the ROC curves for the QUALEFFO-41 and EQ-5D are available in Figs. 1 and 2.
Table 5
ROC curve analysis of QUALEFFO-41 and EQ-5D
Field
QUALEFFO-41 area (SE)
QUALEFFO-41 CI
QUALEFFO-41 p-value
EQ-5D area (SE)
EQ-5D CI
EQ-5D p-value
Pain
0.63 (0.050)
0.53–0.73
p = 0.008
0.68 (0.05)
0.59–0.77
p = 0.001
Physical Function
0.75 (0.043)
0.67–0.84
p < 0.001
0.77 (0.041)
0.69–0.85
p < 0.001
Leisure and social activity
0.70 (0.046)
0.62–0.80
p < 0.001
General health condition
0.70 (0.045)
0.61–0.78
p < 0.001
Mental functioning
0.71 (0.044)
0.62–0.80
p < 0.001
0.65
0.55–0.75
p = 0.003
Overall score
0.767 (0.043)
0.68–0.85
p < 0.001
0.756 (0.041)
0.68–0.84
p < 0.001
SE standard error, CI confidence interval
Fig. 1
Receiver operating characteristic (ROC) curve for the QUALEFFO-41 questionnaire and EQ-5D
Bild vergrößern
Fig. 2
Receiver operating characteristic (ROC) curves for different domains of the Hebrew QUALEFFO-41 questionnaire. The graph displays the sensitivity versus 1-specificity for total averaged (T_Av) scores in pain (T_Av_Pain), usual tasks (T_Av_Usual_task), home tasks (T_Av_home_task), mobility (T_Av_mobility), social functioning (T_Av_social), general health perception (T_Av_healthy), and depression (T_Av_depression) domains. The diagonal reference line represents random classification (AUC = 0.5). Curves further from the reference line and closer to the upper left corner indicate better diagnostic performance. The averaged scores for home tasks and mobility domains demonstrated the highest diagnostic accuracy in distinguishing between women with and without vertebral fractures
Bild vergrößern

Discussion

This study successfully performed a transcultural adaptation and validation of the QUALEFFO-41 questionnaire for Hebrew-speaking patients, demonstrating a moderate reliability and validity for this population. The translation process followed rigorous, internationally recommended guidelines [17], and the final version of the questionnaire was determined following a thorough review and discussion among the translators. A small preliminary group of respondents found the questionnaire clear and relevant, suggesting its potential usefulness in larger-scale studies or clinical settings.
The reliability of the QUALEFFO-41 questionnaire was confirmed by satisfactory internal consistency (Cronbach’s alpha > 0.70) and test–retest reliability (ICC > 0.70) across both groups. These results indicate that the questionnaire consistently captures the intended variables. However, a slightly higher Cronbach’s alpha in the pain domain suggests potential redundancy in questions, while lower consistency in the mental, leisure, and social activity domains may indicate a need for further refinement in these areas.
The construct validity of the QUALEFFO-41 questionnaire was established through discriminant and convergent validity analyses. The majority of the questions showed strong relationships with their respective domains, demonstrating good discriminant validity. Convergent validity was observed in most questions, although exceptions were noted in the mental and leisure fields, further highlighting the need for refinement in these domains. A significant correlation between the QUALEFFO-41 and EQ-5D scores confirmed concurrent validity. The strong positive relationship between the respective domains of the two questionnaires suggests that they similarly capture the intended variables, supporting their cross-cultural applicability and potential interchangeability. Furthermore, the questionnaire demonstrated good discriminant validity, with osteoporotic patients scoring significantly higher on the QUALEFFO-41 than controls, reflecting a higher impact of osteoporosis on their quality of life. This finding underscores the questionnaire’s ability to differentiate between individuals with and without osteoporosis-related quality of life impairments.
Both questionnaires showed acceptable results in terms of sensitivity and specificity. The AUC analysis suggests that the questionnaires can marginally and adequately distinguish between women with and without vertebral fractures. However, the domains of pain and basic daily activities were less effective in diagnosing a spinal fracture, suggesting these areas may need further development.
Data analysis revealed that women in the OVF group were significantly older than women in the OPC group. The average age of the women was 77 and 70, respectively. This finding is consistent with previous studies conducted on the subject. For instance, in a study by Oleksik et al. [20], the average age of women in the study group was 69, while in the control group, it was 62. Similarly, in a study by Tadic et al. [11], the average age of women in the study group was 72, whereas in the control group, it was 63. This observation is logical, considering that, as age increases, bones become more fragile and susceptible to fractures. Considering our main aim was to validate the questionnaire, the age discrepancy does not detract from its ability to accurately capture quality-of-life differences related to vertebral fractures.
Our findings emphasize the role of the QUALEFFO-41 and EQ-5D questionnaires as practical tools in assessing the quality of life and health status of postmenopausal women with osteoporosis and their potential in identifying those with vertebral fractures. This could contribute to early detection, timely intervention, and improved management of osteoporosis. Another potential area for future research is the investigation of the questionnaire’s responsiveness to change over time. Longitudinal studies assessing the questionnaire’s ability to detect changes in quality of life following interventions or disease progression can provide evidence of its usefulness in monitoring treatment effectiveness and informing clinical decision-making.
Several limitations exist in this study. The sample size was relatively small, and our participants were exclusively postmenopausal from the same city and mainly from the same medical center, potentially affecting the generalizability of the results. Additionally, we did not record what kind of medication our participants took, which may have affected quality of life scores; future studies should assess this relationship. Finally, the questionnaire was not tested on women from the general population compared to women with OP without fracture, making it impossible to assess specificity and sensitivity using the ROC curve for women with OP without fracture. Future research should further validate the questionnaire in more extensive and more diverse populations, assess its diagnostic accuracy in detecting osteoporosis-related quality-of-life impairments, and evaluate its responsiveness to change over time.

Conclusion

This study demonstrates that the reliability and validity of the Hebrew version of the QUALEFFO-41 questionnaire for assessing the quality of life in Israeli postmenopausal women with osteoporosis and vertebral fractures is moderate. The questionnaire exhibits moderate internal consistency, test–retest reliability, concurrent validity, and discriminant validity. Further refinement in certain domains may enhance its psychometric properties and diagnostic accuracy. The current findings support using the questionnaire as a tool in clinical and research settings. Future research should focus on validating the questionnaire in more extensive and diverse populations to establish its generalizability.

Declarations

Ethics approval

The study was approved by Tel-Aviv University’s Ethical Review Board on December 27 th, 2015. Additionally, the study was approved by the Institutional Helsinki Committee of Meir Medical Center, Clalit Health Services, Kfar Saba, Israel, on the 23rd of February 2016. The authors declare that the study was performed according to the Good Clinical Practice Guidelines.

Conflicts of interest

None.
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Download
Titel
Transcultural adaptation and validation of the QUALEFFO-41 Questionnaire for Hebrew-Speaking Israeli women with postmenopausal osteoporosis with and without vertebral fractures
Verfasst von
Youssef Masharawi
Avital Lerner
Asaf Weisman
Publikationsdatum
28.05.2025
Verlag
Springer London
Erschienen in
Osteoporosis International / Ausgabe 7/2025
Print ISSN: 0937-941X
Elektronische ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-025-07526-w
1.
Zurück zum Zitat Khandelwal S, Lane NE (2023) Osteoporosis: review of etiology, mechanisms, and approach to management in the aging population. Endocrinol Metabol Clin 52(2):259–275CrossRef
2.
Zurück zum Zitat Skjødt MK, Abrahamsen B (2023) New insights in the pathophysiology, epidemiology, and response to treatment of osteoporotic vertebral fractures. J Clin Endocrinol Metabol 108(11):e1175–e1185CrossRef
3.
Zurück zum Zitat Han CS et al (2023) Red flags to screen for vertebral fracture in people presenting with low back pain. Cochrane Database Syst Rev 7:CD014461
4.
Zurück zum Zitat Gao S, Zhao Y (2023) Quality of life in postmenopausal women with osteoporosis: a systematic review and meta-analysis. Qual Life Res 32(6):1551–1565CrossRefPubMed
5.
Zurück zum Zitat Al-Sari UA, Tobias J, Clark E (2016) Health-related quality of life in older people with osteoporotic vertebral fractures: a systematic review and meta-analysis. Osteoporosis Int 27(10):2891–2900CrossRef
6.
Zurück zum Zitat Capdevila-Reniu A, Navarro-López M, López-Soto A (2021) Osteoporotic vertebral fractures: a diagnostic challenge in the 21st century. Rev Clín Esp 221(2):118–124CrossRefPubMed
7.
Zurück zum Zitat Lips P et al (1999) Quality of life in patients with vertebral fractures: validation of the quality of life questionnaire of the European Foundation for Osteoporosis (QUALEFFO). Osteoporosis Int 10:150–160CrossRef
8.
Zurück zum Zitat Lee Y-K et al (2019) Transcultural adaptation and psychometric properties of the Korean version of the Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO-41). Arch Osteoporos 14(1):96CrossRefPubMed
9.
Zurück zum Zitat Ramírez Pérez E et al (2008) Cultural adaptation and validation of the Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO) in a Mexican population. Clin Rheumatol 27(2):151–161CrossRefPubMed
10.
Zurück zum Zitat Azimi P et al (2014) An outcome measure of functionality and quality of life in Iranian women with osteoporotic vertebral fractures: a validation study of the QUALEFFO-41. J Orthop Sci 19(6):860–867CrossRefPubMed
11.
Zurück zum Zitat Tadic I et al (2012) Validation of the osteoporosis quality of life questionnaire QUALEFFO-41 for the Serbian population. Health Qual Life Outcomes 10(1):74CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Rostom S et al (2012) Psychometric properties evaluation of the quality of life Questionnaire of the European foundation for Osteoporosis in Arabic population. Rheumatol Int 32(7):2037–2049CrossRefPubMed
13.
Zurück zum Zitat Nagammai T et al (2015) Validation of the Malay version of the Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO-41) in Malaysia. Qual Life Res 24(8):2031–2037CrossRefPubMed
14.
Zurück zum Zitat de Oliveira Ferreira N et al (2013) Validation of the Portuguese version of the quality of life questionnaire of the European foundation for osteoporosis (QUALEFFO-41) in Brazilian women with postmenopausal osteoporosis with vertebral fracture. Clin Rheumatol 32(11):1585–1592CrossRefPubMed
15.
Zurück zum Zitat Choo YW et al (2024) Health-related quality of life in osteoporosis: a systematic review of measurement properties of the QUALEFFO-41. Osteoporos Int 35(5):745–757CrossRefPubMed
16.
Zurück zum Zitat Asaf Weisman PhC, M., M. Tomer Yona PhC, and M. Uri Gottlieb PhC, The Reliability and validity of an online version of the Hebrew Patient Health Questionnaire (PHQ-9) in the general population. Isr J Psychiatry, 2022. 59(2): p. 28–32.
17.
Zurück zum Zitat Mokkink LB et al (2018) COSMIN methodology for systematic reviews of patient-reported outcome measures (PROMs). User manual 78(1):6–3
18.
Zurück zum Zitat Einav Horowitz, M., M. Mordechai Shani, and M. Joshua Shemer, eQ-5d as a generic measure of health-related quality of life in Israel: reliability, validity and responsiveness. Isr Med Assoc J. 2010. 4(5): p. 715–720.
19.
Zurück zum Zitat Devlin NJ, Brooks R (2017) EQ-5D and the EuroQol group: past, present and future. Appl Health Econ Health Policy 15(2):127–137CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Oleksik A et al (2000) Health-related quality of life in postmenopausal women With low BMD with or without prevalent vertebral fractures1*. J Bone Min Res 15(7):1384–1392CrossRef

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie erweitert durch Fallbeispiele, Videos und Abbildungen. Zur Fortbildung und Wissenserweiterung, verfasst und geprüft von Expertinnen und Experten der Gesellschaft für Arthroskopie und Gelenkchirurgie (AGA).


Jetzt entdecken!

Neu im Fachgebiet Orthopädie und Unfallchirurgie

Linkshändige orthopädische Chirurgen: Spezies mit Handicap?

Es ist jetzt auch schon wieder rund 600 Millionen Jahre her, dass sich mit dem Erscheinen der Zweiseitentiere die Lateralität ausgebildet hat. In chirurgischen Fächern wie der Orthopädie hat das Folgen bis auf den heutigen Tag. Linkshänder wissen, wovon die Rede ist.

Mit Glukokortikoiden überbrücken? Studie stützt europäische Rheuma-Leitlinie

Glukokortikoide, die zu Beginn einer krankheitsmodifizierenden Rheumatherapie begleitend eingesetzt werden, lassen sich in den allermeisten Fällen planmäßig ausschleichen und absetzen: Das Ergebnis der ARCTIC-Studie spricht diesbezüglich für die europäische und gegen die US-amerikanische Leitlinie.

7% durch chronische Schmerzen stark beeinträchtigt

Laut einer Querschnittstudie leiden rund 7% der in Deutschland lebenden über 16-Jährigen unter chronischen Schmerzen, die ihren Alltag stark beeinträchtigen. Außer biologischen scheinen auch psychische und soziale Faktoren mit sogenanntem High-Impact Chronic Pain assoziiert zu sein.

Elektroschrott: Wie Praxen Altgeräte sicher entsorgen

Ob nun Sonogerät, Praxiscomputer oder gar TI-Konnektor: Einfach zum nächsten Wertstoffhof sollten Praxisteams ausgediente Elektrogeräte nicht bringen. Was bei der Entsorgung zu beachten ist. Und wie die Teams sicher sensible Daten auf PC-Festplatte, externem Datenspeicher und TI-Komponenten löschen.

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Bildnachweise
Arthropedia, Hand greift nach Skalpell/© Morsa Images / Getty Images / iStock, Verschiedene Tabletten/© zozzzzo / Getty Images / iStock, Ultraschalluntersuchung der Niere/© Your_Photo_Today (Symbolbild mit Fotomodellen)